Entry |
|
Name |
Tioconazole (JAN/USP/INN); Vagistat-1 (TN) |
Formula |
C16H13Cl3N2OS
|
Exact mass |
385.9814
|
Mol weight |
387.7112
|
Structure |

|
Simcomp |
|
Class |
Antifungal
DG01883 Imidazole antifungal
|
Remark |
|
Efficacy |
Antifungal, Ergosterol biosynthesis inhibitor |
Comment |
Imidazole derivative
|
Target |
sterol 14alpha-demethylase [KO: K05917] |
Pathway |
|
Interaction |
|
Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
D DERMATOLOGICALS
D01 ANTIFUNGALS FOR DERMATOLOGICAL USE
D01A ANTIFUNGALS FOR TOPICAL USE
D01AC Imidazole and triazole derivatives
D01AC07 Tioconazole
D00890 Tioconazole (JAN/USP/INN)
G GENITO URINARY SYSTEM AND SEX HORMONES
G01 GYNECOLOGICAL ANTIINFECTIVES AND ANTISEPTICS
G01A ANTIINFECTIVES AND ANTISEPTICS, EXCL. COMBINATIONS WITH CORTICOSTEROIDS
G01AF Imidazole derivatives
G01AF08 Tioconazole
D00890 Tioconazole (JAN/USP/INN)
Risk category of Japanese OTC drugs [BR:br08312]
Second-class OTC drugs
Inorganic and organic chemicals
Tioconazole
D00890 Tioconazole (JAN/USP/INN)
Rx-to-OTC switch list in the USA [br08315.html]
D00890
Rx-to-OTC switch list in Japan [br08314.html]
D00890
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 23
1 C1c C 25.5438 -16.1821
2 C8y C 25.5381 -17.5815
3 C1b C 26.7625 -15.4824
4 O2a O 24.3310 -15.4707
5 C8y C 24.3194 -18.2754
6 C8x C 26.7508 -18.2811
7 N4y N 27.9638 -16.1821
8 C1b C 23.1123 -16.1704
9 C8x C 24.3136 -19.6748
10 X Cl 23.1066 -17.5699
11 C8x C 26.7451 -19.6865
12 C8x C 29.1242 -15.3890
13 C8x C 28.3603 -17.5232
14 C8y C 21.8936 -15.4707
15 C8y C 25.5264 -20.3862
16 C8x C 30.2262 -16.2345
17 N5x N 29.7655 -17.4882
18 C8y C 20.7916 -16.3219
19 C8x C 21.4273 -14.1586
20 X Cl 25.5206 -21.7857
21 S2x S 19.6370 -15.5348
22 X Cl 20.7800 -17.7097
23 C8x C 20.0278 -14.1236
BOND 25
1 1 2 1
2 1 3 1
3 1 4 1
4 2 5 2
5 2 6 1
6 3 7 1
7 4 8 1
8 5 9 1
9 5 10 1
10 6 11 2
11 7 12 1
12 7 13 1
13 8 14 1
14 9 15 2
15 12 16 2
16 13 17 2
17 14 18 2
18 14 19 1
19 15 20 1
20 18 21 1
21 18 22 1
22 19 23 2
23 11 15 1
24 16 17 1
25 21 23 1
|